Zhao Z, Bai H, Duan J C, Wang J
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):301-304. doi: 10.3760/cma.j.cn112152-20200228-00146.
In order to achieve the overall victory over 2019 novel coronavirus disease epidemic, especially to prevent the disease recurrence from rebounding during the resumption of labor, the government has not loosened any control of personnel mobility, which has obviously affected the normal examination and treatment of lung cancer patients under the influence of this epidemic. During the epidemic period, cancer patients with low immunity levels face the double ordeals of disease and epidemic situation. Compared with the general population, they are more likely to be infected with the new coronavirus. Among the infected cancer patients, lung cancer is the most common type. It is necessary to provide more appropriate individualized treatment recommendations for patients with lung cancer based on the epidemic situation of the patient's location and in combination with the patient's own condition. Through active prevention of infection, timely conversion of treatment strategies, online and offline joint control, and positive psychological counseling, we do our best to help patients with lung cancer to survive this difficult period.
为实现新冠肺炎疫情防控的全面胜利,特别是防止复工复产期间疫情复发反弹,政府对人员流动的管控丝毫未放松,这在疫情影响下明显影响了肺癌患者的正常诊疗。疫情期间,免疫力水平较低的癌症患者面临疾病与疫情的双重考验。与普通人群相比,他们更容易感染新型冠状病毒。在感染的癌症患者中,肺癌是最常见的类型。有必要根据患者所在地的疫情情况并结合患者自身状况,为肺癌患者提供更适宜的个体化治疗建议。通过积极预防感染、及时转换治疗策略、线上线下联合防控以及积极的心理疏导,尽最大努力帮助肺癌患者度过这一艰难时期。